Citation

Hagen P, D'Souza A, Hari P, Davila O, Zhang M-J, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: Long term follow up of a novel high dose regimen. Leukemia & Lymphoma. 2020 Dec 1; 61(14):3484-3492. doi:10.1080/10428194.2020.1811275. Epub 2020 Aug 31. PMCID:PMC7786301.

Presentation(s)

2019, ASH

PubMed
PMID: 32865474
Abstract

Working Committee Contact

Omar Dávila (Unknown)
odavila@mcw.edu